The stereochemical outcome of the alkylation of simple phenylglycinol-derived bicyclic lactams has been studied. The method provides a simple and concise route to 3-alkylpiperidines in both enantiomeric series. The synthesis of (+)-R-decarbomethoxytetrahydrosecodine, an indole alkaloid embodying a 3-ethylpiperidine moiety, is reported.
Introduction
Chiral non-racemic bicyclic -lactams formed by cyclo-condensation of simple -oxoesters and (R)-or (S)-phenylglycinol have emerged as powerful materials for easy access to a variety of enantiopure substituted piperidines by stereoselective introduction of the substituents on the ring, taking advantage of the functionalization and conformational rigidity of the bicyclic lactam system.1 In this context, we have published a preliminary report 2 that alkylation of the enolate derived from the lactam carbonyl takes place with high facial stereoselectivity to give, ultimately, enantiopure 3-alkylpiperidines.
Although alkylation at the position α-to the carbonyl group of bicyclic γ-and δ-lactams derived from phenylglycinol or other chiral aminoalcohols has received considerable attention, both from the synthetic and theoretical standpoint, 3 the origin of the facial stereoselectivity remains controversial and the observed stereoselectivities are difficult to rationalize. We report here a short and convenient route for the synthesis of enantiopure 3-alkylpiperidines based on the alkylation of simple phenylglycinol-derived bicyclic lactams, cis-1 and trans-1, and illustrate the potential and usefulness of this approach with the enantioselective synthesis of (+)-Rdecarbomethoxytetrahydrosecodine, an indole containing a 3-ethylpiperidine moiety, and its enantiomer.
by X-ray analysis.
In contrast with the above satisfactory results, alkylation (LiHMDS) of the lactam (-)-cis-1 with ethyl iodide took place with moderate stereoselectivity to give a 1:2 diastereomeric mixture of exo-and endo-lactams (-)-6 and (-)-7 in 77% overall yield. The configuration of the stereocenter (C-6) generated in the above alkylation was determined by equilibration experiments. Thus, treatment of the major endo epimer (-)-7 with TFA in CH 2 Cl 2 led to the previously prepared lactam (-)-4 [(-)-4/(-)-7 in a 13:1 ratio], whereas the minor exo epimer (-)-6 was converted to a 2:1 mixture of a new lactam (-)-8 and (-)-6.
Treatment of lactam (-)-4 with LiAlH 4 brought about both the reduction of the lactam carbonyl group and reductive cleavage of the oxazolidine ring to give the piperidine (-)-9. A similar reduction of (-)-7 led to the same piperidine (-)-9, thus confirming that (-)-4 and (-)-7 are epimers at the methine 8a-carbon. Finally, removal of the chiral auxiliary by hydrogenolysis in the presence of Pd/C gave (S)-3-ethylpiperidine (-)-11 in 76% yield. By following a similar sequence, the minor epimeric lactams (-)-6 and (-)-8 were converted to piperidine (+)-10 and then to (R)-3-ethylpiperidine (+)-11.
A more convenient access to 3-alkylpiperidines in the R-enantiomeric series simply involves starting from (S)-phenylglycinol, which is also commercially available. Thus, the bicyclic lactam (+)-trans-1 was alkylated stereoselectively to (+)-4 and then converted in excellent yield to (R)-3-ethylpiperidine (+)-11 via the piperidine (+)-9 (Scheme 2; see Experimental Section). The above approach provides a simple and concise route to 3-alkylpiperidines in both enantiomeric series. It is worth mentioning that, with only one recent exception, 8 both (R)-and (S)-3-ethylpiperidine have been obtained previously by resolution of the racemate.
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To illustrate the potential of chiral lactams 1, the enantiopure piperidines (+)-11 and (-)-11 were alkylated with 3-(2-bromoethyl)-2-ethylindole 2b to give, respectively the alkaloid (+)-decarbomethoxytetrahydrosecodine and its enantiomer.
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General procedure for the alkylation of lactams cis-1 and trans-1. Equilibration of (-)-6 and (-)-7. TFA (1 mL) was added to a solution of (-)-6 (315 mg, 1.29 mmol) in CH 2 Cl 2 (25 mL) and the mixture was stirred at RT for 40 h. Then CH 2 Cl 2 was added, and the mixture was washed with saturated aqueous NaHCO 3 and water. The organic phase was dried and concentrated to afford (-)-6 and (-)- 8 General procedure for LiAlH4 reduction LiAlH4 (500 mg, 13.2 mmol) was added in portions to a solution of lactams 4, 6, 7, or 8 (1 g, 4.08 mmol) in THF (50 mL). The mixture was stirred at RT for 1 h. Then 15% aqueous NaOH was carefully added, the resulting suspension was filtered, and the residue was washed with Et 2 O. The combined organic extracts were concentrated to give (902 mg, 95%) of the respective piperidines, 9 (from 4 or 7) or 10 (from 6 or 8). 3H, 2.17 (td, J = 11.2, 3.4 Hz, 1H, 2H, 3.27 (br. s, 1H, OH) , 77.20; H, 9.94; N, 6.00. Found C, 77.20; H, 10.04; N, 22 D -15.9 (c 0.9 CH 2 Cl 2 ).
General procedure for debenzylation reaction (S)-and (R)-3-ethylpiperidine [(-)-11 and (+)-11].
A solution of the ethylpiperidine (-)-9 or (-)-10 (950 mg, 4.08 mmol) in methanol-HCl (10 mL) was concentrated to give a residue, which was dissolved in methanol (50 mL). The resulting solution containing 5% Pd/C (100 mg) was hydrogenated at RT until starting material disappeared in the TLC. The catalyst was removed by filtration, and the solvent was evaporated. 
